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Objective: To determine the prevalence of the Torque teno virus in healthy donors in the
northern and northwestern regions of the state of Paraná, southern Brazil.
Methods: The Torque teno virus was detected by a nested polymerase chain reaction using
a  set of oligoprimers for the N22 region.
Results: The prevalence of the virus was 69% in 551 healthy blood donors in southern Brazil.
There  was no statistically signiﬁcant difference between the presence of the virus and the
variables gender, ethnicity and marital status. There was signiﬁcant difference in the preva-
lence of the virus regarding the age of the donors (p-value = 0.024) with a higher incidence
(74.7%) in 18- to 24-year-old donors.
Conclusion: A high prevalence of Torque teno virus was observed in the population stud-
ied.  Further studies are needed to elucidate the routes of contamination and the clinical
implications of the virus in the healthy population.©  2015 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.
diseases, respiratory conditions and cancer. However, infor-Introduction
The Torque teno virus (TTV) was ﬁrst detected in 1997 in the
blood of Japanese patients with post-transfusion hepatitis.1,2The virus was also detected in the liver and blood of people
with hepatic pathologies of unknown etiology.2 The associ-
ation between TTV and liver diseases is still controversial,
∗ Corresponding author at: Laboratório de Imunogenética, Universidade
Maringá, PR, Brazil.
E-mail addresses: sueliborelli@gmail.com, sdborelli@uem.br (S.D. Bo
http://dx.doi.org/10.1016/j.bjhh.2015.07.005
1516-8484/© 2015 Associac¸ão Brasileira de Hematologia, Hemoterapia
reserved.and several studies have been undertaken to identify infection
sources.3–5
Epidemiological studies have evidenced the prevalence of
TTV in other pathological conditions, such as in autoimmune
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relli).
mation is still lacking on TTV infection and the development of
pathologies, as well as the change in the course of a particular
disease.3,5
 e Terapia Celular. Published by Elsevier Editora Ltda. All rights
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Table 1 – Prevalence of Torque teno virus in healthy populations of different Brazilian states.
Reference Year of publication State Samples tested TTV DNA
n (%)
Niel et al.17 1999 Rio de Janeiro 72 62.0
Bassit et al.18 2002 São Paulo 197 85.3
de Castro Amarante et al.19 2007 São Paulo 270 50.5
Pinto et al.20 2007 Pará 186 60.0
Nasser et al.4 2009 Paraná 100 6.0
Costa et al.5 2012 Mato Grosso do Sul 46 15.2
Massaú et al.21 2012 Rio Grande do Sul 150 73.3
v
i
b
a
(
H
(
i
M
i
s
ﬁ
e
c
b
s
(
v
r
d
m
m
v
K
s
t
g
t
o
r
t
B
M
T
s
c
sTTV: Torque teno virus.
Blood transfusion was initially indicated as the principal
ia of viral transmission due to direct contact with contam-
nated blood. Despite the progress in pretransfusion safety,
lood recipients are not free from risk of contamination.8
The serological tests performed on blood donors in Brazil
re established by the national health surveillance agency
ANVISA), and include serology for HIV1 and HIV2, HTLVI and
TLVII, hepatitis B (HBV), hepatitis C (HCV), Trypanosoma cruzi
Chagas disease), Treponema pallidum (syphilis) and Plasmodium
n endemic areas of malaria.9
Besides the serological tests conducted according to the
inistry of Health protocol, there is concern about the emerg-
ng and re-emerging diseases that can affect transfusion
afety.10
However, new routes of transmission have been identi-
ed, due to the presence of the virus in different biological
xcretions such as in feces,11 saliva12 and also in river water
ontaminated by sewage.13
Currently, wide variability in the prevalence of TTV has
een observed in healthy populations in different countries,
uch as in Alexandria in Egypt (48.4%),14 United Arab Emirates
75.0%)15 and Iran (13.4%).16 In Brazil the prevalence of TTV
aries from 6 to 85% in different states (Table 1).
Several factors may contribute to the variability of the
esults of TTV prevalence studies, such as the geographical
istribution of the population under analysis, the diagnostic
ethod used, the size of the study group and the difﬁculty of
aking a single set of primers able to identify the majority of
iral genotypes.10,15
TTV infection is common in healthy donors worldwide.15,19
nowledge of the prevalence of the TT virus in speciﬁc regions,
erves as a resource to elucidate the transmission routes and
he possible cause of disease, and may assist in developing
uidelines for actions to control virus transmission in popula-
ions. The aim of this study was to determine the prevalence
f TTV in healthy donors in the northern and northwestern
egions of Paraná state, as there is a lack of studies showing
he prevalence of the TTV virus in healthy donors in southern
razil.
ethodshis transverse quantitative analysis involves human DNA
amples obtained from healthy donors in 2010. The population
omprised 551 volunteers, aged between 18 and 55 years. The
amples were grouped according to the geographic location ofthe source, in one of the seven mesoregions of Paraná State,
according to the Brazilian Institute of Geography and Statistics
(IBGE) (Northwest, Central-West, North-Central, the region of
Norte Pioneiro, Central-Eastern, Mid-South and Metropolitan
region of Curitiba) and other states.
A nested polymerase chain reaction (nested PCR) with spe-
ciﬁc primers for the N22 codifying region (ORF1 Open Reading
Frame 1) was employed to detect TTV DNA. A sense primer
(RD037) followed by oligonucleotide primers 5′ GCA GCAGCA
TAT GGA TAT GT 3′ and RD038 (5′ TGA CTG TGC TAA GGC  CTC
TA 3′) were employed in the ﬁrst ampliﬁcation. The product
of the ﬁrst ampliﬁcation and the antisense primers RD051 5′
CAT ACA CAT GAA TGC CAG GC 3′ and RD052 5′ GTA CTT CTT
GCT GGT GAA AT 3′ were used in the second ampliﬁcation. All
reagents were identical in both reactions with a ﬁnal volume
of 25.0 L comprised of 2.5 L PCR buffer, 0.75 L 50 mM mag-
nesium chloride (MgCl2), 2.0 L 1.25 mM deoxyribonucleotide
phosphate (dNTP), 1.0 L of each sense (2.5 M) and antisense
(2.5 M) primer, 2.5 L Taq DNA polymerase (Invitrogen Life
Technologies Brazil), and 12.75 L sterile MilliQ water. A fur-
ther 2.5 L genomic DNA was used for the ﬁrst ampliﬁcation,
and 2.5 L of the product from the ﬁrst ampliﬁcation was used
for the second ampliﬁcation. Both reactions occurred in a ther-
mocycler (Applied Biosystems) device with denaturing at 94 ◦C
for 30 s, followed by 35 cycles at 53 ◦C for 30 s for primer anneal-
ing, 72 ◦C for 45 s for primer extension, with a ﬁnal extension
at 72 ◦C for 10 min. The ampliﬁed DNA products were ana-
lyzed by 2% agarose gel electrophoresis, stained with SYBR®
Safe (1 L/10 mL  gel), and photographed under UV light. The
DNA Ladder (Invitrogen) consisted of 50 base pairs (bp) and the
ampliﬁed DNA products of 197 bp. All tests included a pos-
itive control (TTV genomic DNA). Data were analyzed with
the Statistic 7.0 computer program using the chi-squared test,
Yates’s continuity correction and Fisher’s exact test with sig-
niﬁcance set at a level of 5%. The assay complied with all
ethical guidelines and was approved by the Research Ethics
Committee of the Universidade Estadual de Maringá (UEM),
Paraná, Brazil (Process 271/2011).
Results
The demographic data and the prevalence of TTV in healthy
blood donors are shown in Table 2. The mean age of the donors
was 33.7 years, and the majority were women 62.6% (345/551).
Most of the donors were Caucasian 83.1% (458/551). TTV viral
DNA was detected in 69% (380/551) of blood donors. Among the
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Table 2 – Demographic characteristics and prevalence of Torque teno virus among healthy blood donors.
TTV TTV Total p-Value
Positive
n (%)
Negative
n  (%)
Gender 0.785
Male 144 (70.0) 62 (30.0) 206
Female 236 (68.4) 109 (31.6) 315
Age (years) 0.024
18–24 124 (74.7) 42 (25.3) 166
25–38 154 (70.3) 65 (29.7) 219
39–53 97 (63.0) 57 (37.0) 154
54–55 5 (41.7) 7 (58.3) 12
Ethnic background 0.999
Caucasian 316 (69.0) 142 (31.0) 458
African descent 64 (68.8) 29 (31.2) 93
Marital status 0.916
Married 183 (68.0) 86 (32.0) 269
Single 170 (69.7) 74 (30.3) 244
Othersa 27 (71.1) 11 (28.9) 38TTV: Torque teno virus.
a Widowed, separated, divorced or cohabiting.
sociodemographic variables, the proportion of TTV-positive
individuals differed in respect to age (Fisher’s exact test: p-
value = 0.024), with the rate being higher in the 18–24 year olds.
There was no statistically signiﬁcant difference in the preva-
lence of the virus between gender and ethnic background
(p-value > 0.05).
The prevalence of TTV in healthy blood donors was
assessed by mesoregion of the state of Paraná, southern Brazil
(Table 3). The statistics test (Chi squared with Yates correction)
indicated no signiﬁcant differences in the presence of the virus
and the different mesoregions (p-value = 0.576).
Discussion
The prevalence of TTV in blood donors in the mesoregions of
the state of Paraná in southern Brazil was 69%. Other stud-
ies in Brazilian populations showed 60% prevalence in Belém,
Pará20 and 50.5% in the southeastern region of the state of São
Paulo.18 In southern Brazil, studies showed a high prevalence
of the virus in healthy donors (73.3%) in the municipality of
Pelotas, RS21 and also the presence of the virus in samples of
drinking water and sewage water.13,22
TTV transmission by blood transfusion has been a recur-
ring concern since the 1990s.1 In Brazil, a study conducted at
a university hospital showed concern about the risk of viral
transmission by blood transfusion,23 the serological screening
of donors cannot provide complete protection from the trans-
mission of infectious agents.
Similar to TTV, other viruses related to liver damage are
overlooked in blood donors, including the hepatitis G virus
(HGV). Some studies have shown the prevalence of HGV in
healthy populations of Japan (0.9%) and South Africa (18.9%).24In Brazil a prevalence of 7.1% was also shown in the state of
Goias25 and 9.7% in São Paulo.26
Although TTV contamination can occur from both con-
taminated blood and blood products,2 there is no speciﬁclegislation that requires testing of blood donors for the virus.
Therefore, little is known about the routes of transmission
and diseases originating from the presence of the virus in the
human population.
Based on the results presented, the association of the
virus with the study variables can be determined (Table 2).
The prevalence of TTV infection was (380/69%) in healthy
donors from the northern and northwestern regions of Paraná,
slightly below that found in Rio Grande do Sul (73.3%)21 and
the region of São Paulo (85.3%).18 However, one should also
note that the prevalence of the virus in other countries ranged
from 2.7 to 79.5%.10 The variables of gender, race (Caucasian
or African descent), and marital status showed no statistical
association with the presence of the virus. The results of this
study are in agreement with other studies that have suggested
that TTV infection is relatively common in different popula-
tions and in different regions of the world.1,2
With respect to age groups, the study included individuals
between 18 and 55 years and revealed a high prevalence of
infected young people between 18 and 24 (74.7%). However,
it was found that the prevalence declined in over 24-year-
old individuals, especially those of 54 and 55 (41.7%). This
contrasts with previous studies that showed a cumulative
prevalence with increasing age, or the presence of the virus
independently of age.27
Several studies conducted in different countries and
individuals in different age groups demonstrated varying
prevalences for TTV.18,28 The discussion of other age groups
is limited by the particular population selected for this study.
The results of this study indicated that the presence of
TTV was signiﬁcantly associated with age (p-value = 0.024), in
agreement with a study in Pelotas, southern Brazil.21
The data for mesoregions (Table 3) indicate that there was
no statistically signiﬁcant difference between the presence of
the virus and the samples from donors from different regions
of Paraná. The grouping in mesoregions was necessary due to
the large number of municipalities that comprised this study.
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Table 3 – Distribution of the prevalence of Torque teno virus in healthy blood donors.
TTV TTV Total p-Value
Positive
n (%)
Negative
n  (%)
n  (%)
Mesoregions 0.576
North-West 169 (68.7) 77 (31.3) 246 (45.0)
Central-West 4 (80.0) 1 (20.0) 5 (0.9)
North-Central 200 (68.5) 92 (31.5) 292 (53.0)
Norte Pioneiro 1 (100.0) 0 1 (0.2)
Central-East 0 1 (100.0) 1 (0.2)
Central-South 2 (100.0) 0 2 (0.4)
Metropolitan Curitiba 1 (100.0) 0 1 (0.2)
Other States 3 (100.0) 0 3 (0.5)
Total 380 (69.0) 171 (31.0) 551 (100.0)
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ost of the donors were from the north-central and north-
est Paraná mesoregions (98%) with prevalences of 68.5% and
8.7%, respectively. These regions belong to the 15th Regional
ealth District of Paraná and refer the city of Maringa, Parana,
razil. Abe et al. demonstrated that the TTV virus is widely
istributed in different regions of the planet, and with high
revalence rates.29
As is apparent from the literature, several factors may inﬂu-
nce the variability of results for TTV prevalence, among them
he geographical distribution of the populations studied, the
iagnostic methods of detection, the size of study groups and
he set of primers used in the study.3,15,28
The high rates of viral prevalence may be directly related
o the forms of contamination. A study of samples of blood
nd saliva from the same individuals showed the presence
f the virus in the same proportions regardless of the biolog-
cal sample used.30 The presence of the virus in water has
een investigated over time, and although the purpose of the
resent study was not to demonstrate the presence of virus
n environmental samples, the importance of this analysis for
tudying the viral prevalence in a given region is important.
Studies have detected TTV in 97% of water samples col-
ected in Japan31 and in Brazil, in 92% of samples collected
rom rivers and streams in Manaus.32 The viral genome was
lso reported in samples of drinking water in Rio Grande do
ul.13 The presence of TTV in the water of rivers, lakes, and
reatment plants and especially in drinking water has had a
ajor impact in spreading the virus. This may be related to
he high prevalence of the virus in healthy individuals.
onclusion
his study found a high prevalence of TTV in healthy blood
onors, in agreement with other studies in the Brazilian pop-
lation. The clinical signiﬁcance of the presence of the virus
n these donors cannot be evaluated based on this study, but
an serve as a basis for future studies. In view of the differ-
nt transmission routes and the lack of complete information
bout the pathogenesis of TTV, it is important to develop
easures to minimize the risk of transmission of this and
ther viruses among healthcare providers.
1Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
 e  f  e  r  e  n  c  e  s
1. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa
Y,  Mayumi M. A novel DNA virus (TTV) associated with
elevated transaminase levels in posttranfusion hepatitis of
unknown etiology. Biochem Biophys Res Commun.
1997;241(1):92–7.
2. Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H,
et al. Molecular cloning and characterization of a novel DNA
virus (TTV) associated with posttransfusion hepatitis of
unknown etiology. Hepatol Res. 1998;10(1):1–16.
3. Watanabe MA, Miranda HC, Oliveira KB, Oliveira CE, Tristão
FS, Duarte LM, et al. Aspectos patológicos, imunológicos e
propriedades moleculares do TT vírus. J Bras Patol Med Lab.
2005;41(4):223–8.
4. Nasser TF, Brajão de Oliveira K, Reiche EM, Amarante MK,
Pelegrinelli Fungaro MH, Watanabe MA. Detection of TT virus
in  HIV-1 exposed but uninfected individuals and in HIV-1
infected patients and its inﬂuence on CD4+ lymphocytes and
viral load. Microb Pathog. 2009;47(1):33–7.
5. Costa MR, Costa IP, Devalle S, Castro ARCM, Freitas SZ.
Prevalence and genetic diversity of torque teno virus in
patients with systemic lupus erythematosus in a reference
service in Mato Grosso do Sul. Rev Bras Reumatol.
2012;52(1):49–54.
6. Maggi F, Pifferi M, Fornai C, Andreoli E, Tempestini E,
Vatteroni M, et al. TT virus in the nasal secretion of children
with acute respiratory diseases: relations to viremia and
disease severity. J Virol. 2003;77(4):2418–25.
7. Girard C, Ottomani L, Ducos J, Dereure O, Carles MJ,  Guillot B.
High prevalence of Torque Teno (TT) virus in classical
Kaposi’s sarcoma. Acta Derm Venereol. 2007;87(1):14–7.
8. Carrazzone CF, Brito AM, Gomes YM. Importância da
avaliac¸ão sorológica pré-transfusional em receptores de
sangue. Rev Bras Hematol Hemoter. 2004;26(2):93–8.
9. Ministério da Saúde. Agência Nacional de Vigilância
Sanitária. Resoluc¸ão da Diretoria Colegiada (RDC) No 153 de
14  de julho de 2004. Brasília: ANVISA; 2004.0. Karimi G, Gharehbaghian A, Tafti MF, Vafaiyan V. Emerging
infectious threats to the blood supply: soroepidemiological
studies in Iran – a Review. Transfus Med Hemother.
2013;40(3):210–7.
oter.
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3340  rev bras hematol hem
1. Okamoto H, Akahane Y, Ukita M, Fukuda M, Tsuda F,
Miyakawa Y, et al. Fecal excretion of a nonenveloped DNA
virus (TTV) associated with posttransfusion non-A-G
hepatitis. J Med Virol. 1998;56(2):128–32.
2. Naganuma M, Tominaga N, Miyamura T, Soda A, Moriuchi M,
Moriuchi H. TT virus prevalence, viral loads and genotypic
variability in saliva from healthy Japanese children. Acta
Paediatr. 2008;97(12):1686–90.
3. Vecchia AD, Fleck JD, Comerlato J, Kluge M, Bergamaschi B, Da
Silva JV, et al. First description of Adenovirus, Enterovirus,
Rotavirus and Torque teno virus in water samples collected
from the Arroio Dilúvio, Porto Alegre, Brazil. Braz J Biol.
2012;72(2):323–9.
4. Hashish MH, El-Barrawy MA, Mahmoud OA, Abdel Rahman
NW.  TT virus among blood donors in Alexandria. J Egypt
Public Health. 2005;80(5–6):651–64.
5. Alfaresi MS, Elnazer AM, Alzaabi AS, Elkoush AA, Islam AA.
Transfusion transmitted virus in screened United Arab
Emirates blood donors. Saudi Med J. 2006;27(1):58–62.
6. Sara A, Solhjoo K, Jahromi AR, Yaghobi R. Study the
prevalence of TT virus infection in South Iranian volunteer
blood donors. Afr J Microbiol Res. 2012;6(23):5077–81.
7. Niel C, de Oliveira JM, Ross RS, Gomes SA, Roggendorf M,
Viazov S. High prevalence of TT virus infection in Brazilian
blood donors. J Med Virol. 1999;57(3):259–63.
8. Bassit L, Takei K, Hoshino-Shimizu S, Nishiya AS, Sabino EC,
Bassit RP, et al. New Prevalence Estimate of TT virus (TTV)
infection in low- and high-risk population from São Paulo,
Brazil. Rev Inst Med Trop Sao Paulo. 2002;44(4):233–4.
9. de Castro Amarante MF, Kashima S, Covas DT. TT virus (TTV)
genotyping in blood donors and multiple transfused patients
in Brazil. Virus Genes. 2007;35(3):503–9.
0. Pinto WV, Assis MF, Lemos JA. Prevalência do TTV em
doadores de sangue, na região metropolitana de Belém-Pará.
Caderno Saúde Coletiva. 2007;15(3):349–56.1. Massaú A, Martins C, Nachtigal GC, Araujo AB, Rossetti ML,
Niel  C, et al. The high prevalence of Torque Teno Virus DNA in
blood donors and haemodialysis patients in southern Brazil.
Mem Inst Oswaldo Cruz. 2012;107(5):684–6.
3 2 0 1 5;3  7(5):336–340
2. Vecchia AD, Kluge M, dos Santos da Silva JV, Comerlato J,
Rodrigues MT, Fleck JD, et al. Presence of Torque teno virus
(TTV) in tap water in public schools from Southern Brazil.
Food Environ Virol. 2013;5(1):41–5.
3. Schöninger N, Duro CL. Atuac¸ão do enfermeiro em servic¸o de
hemoterapia. Ciênc Cuid Saúde. 2010;9(2):317–24.
4. Sathar MA, Soni PN, York D. GB Virus C/Hepatitis G Virus
(GBV-C/HGV): still looking for a disease. Int J Exp Pathol.
2000;81(5):305–22.
5. Oliveira LA, Martins RM, Carneiro MA, Teles AS, Silva AS,
Cardoso DD, et al. Prevalence and genotypes of GB Virus
C/Hepatitis G virus among blood donors in Central Brazil.
Mem Inst Oswaldo Cruz. 2002;97(7):953–7.
6. Levi JE, Contri DG, Lima LP, Takaoka DT, Garrini RH, Santos W,
et  al. High prevalence of GB Virus C/Hepatitis G Virus RNA
among Brazilian blood donors. Rev Inst Med Trop Sao Paulo.
2003;45(2):75–8.
7. Hsieh SY, Wu YH, Ho YP, Tsao KC, Yeh CT, Lian YF. High
prevalence of TT virus infection in healthy children and
adults and in patients with liver disease in Taiwan. J Clin
Microbiol. 1999;37(6):1829–31.
8. Vasconcelos HC, Menezes ME, Niel C. TT virus infection in
children and adults who visited a general hospital in the
south of Brazil for routine procedure. Mem  Inst Oswaldo Cruz.
2001;96(4):519–22.
9. Abe K, Inami T, Asano K, Miyoshi C, Masaki N, Hayashi S,
et  al. TT virus infection is widespread in the general
populations from different geographic regions. J Clin
Microbiol. 1999;37(8):2703–5.
0. Spandole S, Cimponeriu D, Toma M, Radu I, Ion D. Rapid
detection of human torque teno viruses using high-resolution
melting analysis. Balkan J Med Genet. 2013;16(1):55–62.
1. Haramoto E, Katayama H, Oguma K, Yamashita H, Nakajima
E,  Ohgaki S. One-year monthly monitoring of Torque Teno
Virus (TTV) in wastewater treatment plants in Japan. Water
Res. 2005;39(10):2008–13.
2. Diniz-Mendes L, Paula VS, Luz SL, Niel C. High prevalence of
human Torque Teno virus in streams crossing the city of
Manaus, Brazilian Amazon. J Appl Microbiol. 2008;105(5):51–8.
